Litigation over bans on gender-affirming care in various U.S. states could further establish the authority of politicians and courts to determine treatment options and exacerbate health disparities.
No takes yet. Share an insight, caveat, or question.
Michael R. Ulrich (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: